I agree that this site is using cookies. You can find further informations here.
X
Yu, Yongfeng
1709  results:
english X
Search for persons X
?
1

Cisplatin-induced Pyroptosis Enhances the Efficacy of PD-L1..:

Xuzhang, Wendi ; Lu, Tingting ; Jin, Weiqiu...
International Journal of Biological Sciences.  20 (2024)  2 - p. 537-553 , 2024
Link: https://doi.org/10.7150/..
 
?
2

EGFR mutations induce the suppression of CD8+ T cell and an..:

Huang, Huayan ; Zhu, Xiaokuan ; Yu, Yongfeng...
Journal of Translational Medicine.  22 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
3

EGFR-mutant NSCLC may remodel TME from non-inflamed to infl..:

Chen, Qianqian ; Xia, Liliang ; Wang, Jingze...
Lung Cancer.  192 (2024)  - p. 107815 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Gumarontinib in patients with non-small-cell lung cancer ha..:

Yu, Yongfeng ; Zhou, Jianya ; Li, Xingya...
eClinicalMedicine.  59 (2023)  - p. 101952 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Treatment strategies based on different oligoprogressive pa..:

Xuzhang, Wendi ; Huang, Huayan ; Yu, Yongfeng...
Therapeutic Advances in Medical Oncology.  15 (2023)  - p. 175883592311563 , 2023
Link: https://doi.org/10.1177/..
 
?
6

Chinese multidisciplinary expert consensus on the managemen..:

Zhang, Li ; Wang, Yongsheng ; Lin, Lizhu..
Therapeutic Advances in Medical Oncology.  15 (2023)  - p. , 2023
Link: https://doi.org/10.1177/..
 
?
7

Functional Characterization of a Novel SMR-Type Efflux Pump..:

Quan, Heng ; Gong, Xiaowei ; Chen, Qiwei...
Microorganisms.  11 (2023)  4 - p. 907 , 2023
Link: https://doi.org/10.3390/..
 
?
8

EptA of Riemerella anatipestifer mediates phenotypes involv..:

Chen, Qiwei ; Quan, Heng ; Yu, Yongfeng...
The FASEB Journal.  37 (2023)  5 - p. , 2023
Link: https://doi.org/10.1096/..
 
?
9

Homologous recombination deficiency (HRD) can predict the t..:

Zhou, Zhen ; Ding, Zhengping ; Yuan, Jie...
Journal of Hematology & Oncology.  15 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
10

Proposal for multiple new lesions as complement of hyperpro..:

Wang, Mengxiao ; Huang, Huayan ; Xu, Zhangwendi...
Lung Cancer.  173 (2022)  - p. 28-34 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Comparison of Efficacy and Safety of Brigatinib in First-Li..:

Yu, Yongfeng ; Zhu, Fanfan ; Zhang, Wenxin.
Journal of Clinical Medicine.  11 (2022)  11 - p. 2963 , 2022
Link: https://doi.org/10.3390/..
 
?
12

Circulating tumour DNA biomarkers in savolitinib-treated pa..:

Yu, Yongfeng ; Ren, Yongxin ; Fang, Jian...
Therapeutic Advances in Medical Oncology.  14 (2022)  - p. 175883592211335 , 2022
Link: https://doi.org/10.1177/..
 
?
13

Comprehensive analysis of MET mutations in NSCLC patients i..:

Ai, Xinghao ; Yu, Yongfeng ; Zhao, Jun...
Therapeutic Advances in Medical Oncology.  14 (2022)  - p. 175883592211124 , 2022
Link: https://doi.org/10.1177/..
 
?
14

FGFR1 promotes tumor immune evasion via YAP-mediated PD-L1 ..:

Lu, Min ; Wang, Kaixuan ; Ji, Wenxiang...
Cellular Immunology.  379 (2022)  - p. 104577 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Antimicrobial Resistance Surveillance of Tigecycline-Resist..:

Yu, Yongfeng ; Shao, Changchun ; Gong, Xiaowei...
Microorganisms.  10 (2022)  12 - p. 2432 , 2022
Link: https://doi.org/10.3390/..
 
1-15